Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mesalazine - Tillotts Pharma

Next Previous
X
Search
Drug Profile

Mesalazine - Tillotts Pharma

Alternative Names: Asacol; Asacolon; Fivasa; Lixacol; Octasa; TP-05; YALDIGO; Z 206

Latest Information Update: 21 Apr 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tillotts Pharma
  • Developer Kyowa Hakko Kirin; Kyowa Kirin; Lek Pharmaceuticals d.d.; PENDOPHARM; Tillotts Pharma; Zeria
  • Class Aminosalicylic acids; Anti-inflammatories; Antineoplastics; Irritable bowel syndrome therapies; Small molecules
  • Mechanism of Action Lipoxygenase-cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Crohn's disease; Inflammatory bowel diseases; Proctitis; Ulcerative colitis
  • Phase II Irritable bowel syndrome

Most Recent Events

  • 06 Apr 2023 Launched for Ulcerative colitis (First-line therapy) in Canada (PO) (1600mg)
  • 11 Nov 2022 Mesalazine is licensed to Pendopharm in Canada
  • 11 Nov 2022 Launched for Ulcerative colitis in Canada (PO) (800 mg and delayed-release tablets)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top